Abo
Mann des Monats

Das Umfeld

-

3 Bilder
Dr. Mirjam Staub-Bisang, Vorsitzende der Geschäftsleitung der Vermögensverwaltung Independent Capital Group AG mit Sitz in Zürich, am Montag (27.08.18) in Zürich. Foto: Markus Forte

MIRJAM STAUB-BISANG: Schweiz-Chefin von Grossaktionär Blackrock. 

Markus Forte
Dr. Mirjam Staub-Bisang, Vorsitzende der Geschäftsleitung der Vermögensverwaltung Independent Capital Group AG mit Sitz in Zürich, am Montag (27.08.18) in Zürich. Foto: Markus Forte

MIRJAM STAUB-BISANG: Schweiz-Chefin von Grossaktionär Blackrock. 

Markus Forte

Werbung

Stephane Bancel, chief executive officer of Moderna Therapeutics Inc., stands for a photograph at the company's office in Cambridge, Massachusetts, U.S., on Tuesday, Nov. 14, 2017. Moderna this week started testing a personalized treatment that teaches the body how to fight cancer. Photographer: Adam Glanzman/Bloomberg via Getty Images

STÉPHANE BANCEL: CEO beim Grosskunden Moderna.

Bloomberg via Getty Images
Stephane Bancel, chief executive officer of Moderna Therapeutics Inc., stands for a photograph at the company's office in Cambridge, Massachusetts, U.S., on Tuesday, Nov. 14, 2017. Moderna this week started testing a personalized treatment that teaches the body how to fight cancer. Photographer: Adam Glanzman/Bloomberg via Getty Images

STÉPHANE BANCEL: CEO beim Grosskunden Moderna.

Bloomberg via Getty Images
Pascal Soriot, chief executive officer of Astrazeneca Plc, poses for a photograph before an interview in London, U.K., on Monday, Sept. 4, 2017. Soriot said he’s worried about the lack of progress in negotiations between the U.K. and the European Union on their future ties, which could impede sales of drugs in foreign markets after Brexit. Photographer: Chris Ratcliffe/Bloomberg

PASCAL SORIOT: CEO bei AstraZeneca, auch Covid-Grosskunde bei Lonza. 

Bloomberg
Pascal Soriot, chief executive officer of Astrazeneca Plc, poses for a photograph before an interview in London, U.K., on Monday, Sept. 4, 2017. Soriot said he’s worried about the lack of progress in negotiations between the U.K. and the European Union on their future ties, which could impede sales of drugs in foreign markets after Brexit. Photographer: Chris Ratcliffe/Bloomberg

PASCAL SORIOT: CEO bei AstraZeneca, auch Covid-Grosskunde bei Lonza. 

Bloomberg

Werbung